Quest Diagnostics Forecast, price target & analysts
Quest Diagnostics Target price 2025 - Analyst rating & recommendation
Quest Diagnostics Classifications & Recommendation:
Quest Diagnostics Price Target
| Target Price | $179.60 |
| Price | $171.55 |
| Potential |
4.69%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Quest Diagnostics 2026 .
The average Quest Diagnostics target price is $179.60.
This is
4.69%
register free of charge
$190.00
10.75%
register free of charge
$160.00
6.73%
register free of charge
|
|
| A rating was issued by 21 analysts: 11 Analysts recommend Quest Diagnostics to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Quest Diagnostics stock has an average upside potential 2026 of
4.69%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 9.87 | 10.78 |
| 6.70% | 9.21% | |
| EBITDA Margin | 19.33% | 20.11% |
| 0.10% | 4.05% | |
| Net Margin | 8.61% | 8.75% |
| 4.54% | 1.59% |
15 Analysts have issued a sales forecast Quest Diagnostics 2025 . The average Quest Diagnostics sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Quest Diagnostics EBITDA forecast 2025. The average Quest Diagnostics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Quest Diagnostics Analysts have issued a net profit forecast 2025. The average Quest Diagnostics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 7.66 | 8.50 |
| 1.86% | 10.97% | |
| P/E | 20.18 | |
| EV/Sales | 2.38 |
7 Analysts have issued a Quest Diagnostics forecast for earnings per share. The average Quest Diagnostics <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Quest Diagnostics stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Quest Diagnostics...
Current Quest Diagnostics Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan | Locked ➜ Locked | Locked | Feb 04 2025 |
| UBS | Locked ➜ Locked | Locked | Feb 03 2025 |
| Mizuho | Locked ➜ Locked | Locked | Feb 03 2025 |
| Piper Sandler | Locked ➜ Locked | Locked | Feb 03 2025 |
| Barclays | Locked ➜ Locked | Locked | Jan 31 2025 |
| Truist Securities | Locked ➜ Locked | Locked | Jan 31 2025 |
| Leerink Partners | Locked ➜ Locked | Locked | Jan 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan: Locked ➜ Locked
|
Feb 04 2025 |
|
Locked
UBS: Locked ➜ Locked
|
Feb 03 2025 |
|
Locked
Mizuho: Locked ➜ Locked
|
Feb 03 2025 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Feb 03 2025 |
|
Locked
Barclays: Locked ➜ Locked
|
Jan 31 2025 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Jan 31 2025 |
|
Locked
Leerink Partners: Locked ➜ Locked
|
Jan 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
